These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34487814)

  • 1. Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart Failure.
    Lytvyn Y; Burns KD; Testani JM; Lytvyn A; Ambinathan JPN; Osuntokun O; Godoy LC; Cherney DZI; Parker JD
    J Card Fail; 2022 Mar; 28(3):385-393. PubMed ID: 34487814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.
    Lytvyn Y; Bjornstad P; Lovshin JA; Boulet G; Farooqi MA; Lai V; Tse J; Cham L; Lovblom LE; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Advani A; Sochett E; Perkins BA; Cherney DZI
    Am J Kidney Dis; 2019 Jun; 73(6):786-796. PubMed ID: 30799029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO; MacFadyen RJ; Struthers AD
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurohormonal Activation and Renal Chloride Avidity in Acute Heart Failure: Clinical Evidence Supporting the "Chloride Theory".
    Kataoka H
    Cardiorenal Med; 2024; 14(1):94-104. PubMed ID: 38290488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
    Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.
    Smilde TD; Damman K; van der Harst P; Navis G; Westenbrink BD; Voors AA; Boomsma F; van Veldhuisen DJ; Hillege HL
    Clin Res Cardiol; 2009 Feb; 98(2):121-9. PubMed ID: 18979056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment.
    Reina-Couto M; Afonso J; Carvalho J; Morgado L; Ronchi FA; de Oliveira Leite AP; Dias CC; Casarini DE; Bettencourt P; Albino-Teixeira A; Morato M; Sousa T
    Biomed Pharmacother; 2021 Jan; 133():110938. PubMed ID: 33171402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
    Emdin M; Fatini C; Mirizzi G; Poletti R; Borrelli C; Prontera C; Latini R; Passino C; Clerico A; Vergaro G
    Clin Chim Acta; 2015 Mar; 443():85-93. PubMed ID: 25445411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure.
    Biegus J; Nawrocka-Millward S; Zymliński R; Fudim M; Testani J; Marciniak D; Rosiek-Biegus M; Ponikowska B; Guzik M; Garus M; Ponikowski P
    Int J Cardiol; 2021 Dec; 345():54-60. PubMed ID: 34728260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
    Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction.
    Vaduganathan M; Fonarow GC; Greene SJ; Devore AD; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J
    J Card Fail; 2022 Feb; 28(2):191-201. PubMed ID: 34428591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin and the renin-angiotensin-aldosterone system.
    Charles CJ; Lainchbury JG; Nicholls MG; Rademaker MT; Richards AM; Troughton RW
    Regul Pept; 2003 Apr; 112(1-3):41-9. PubMed ID: 12667624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.